Year-End Late-Stage Pipeline Review
Sanofi is pleased to invite investors and analysts to participate in a year-end late-stage pipeline review by R&D management on Tuesday, December 16, 2025.
Press Releases
Upcoming Events
29Jan
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results will be reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EDT)
Quarterly results
23Apr
First Quarter 2026
First quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.
Quarterly results
30Jul
Second Quarter 2026
Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.
Quarterly results
30Oct
Third Quarter 2026
Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.
Quarterly results
Past Events
24Oct
Third Quarter 2025
Third quarter 2025 results were reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation was followed by a Q&A session.
Quarterly results
31Jul
Second Quarter 2025
Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.
Quarterly results
24Apr
First quarter 2025
First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Quarterly results